-
Notifications
You must be signed in to change notification settings - Fork 36
ModelDrug
ThomasASmith edited this page Jun 2, 2015
·
20 revisions
There are three different ways of modeling antimalarial pharmacokinetics and pharmacodynamics (PK/PD) in OpenMalaria:
- A simple success/failure model in which drug Treatment either clears all infections in the host (
treatSimpleoption in health system / intervention component) or does nothing. This can be extended to include a prophylactic effect which simply removes all new infections for a configurable number of steps in the future. - Clearing infections via above method then using Pre-erythrocytic vaccines to probabilistically prevent reinfection (this allows a slightly more realistic prophylactic effect than the above).
- Explicit pharmacokinetic and pharmacodynamic modeling of drugs (
treatPKPDoption in health system / intervention component), linked to a dynamic model of parasite densities in the course of an infection.
- User Guide
- Compilation Guide
- Developer Guide
- Schema Update Guide
- Scenario Design Guide
- Monitoring Guide
- Changelog
- XML: Example Scenario
- XSD: Schema Documentation
- Human demography
- Transmission and EIR
- Parasite dynamics within humans
- P vivax dynamics
- Vector bionomics and transmission to humans
- Mosquito population dynamics
- Clinical (illness) models
- Time in the models
- Elimination